These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4936883)

  • 1. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
    Malarkey WB; Daughaday WH
    J Clin Endocrinol Metab; 1971 Sep; 33(3):424-31. PubMed ID: 4936883
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsuccessful treatment of acromegaly with medroxyprogesterone acetate.
    Atkinson RL; Dimond RC; Howard WJ; Earll JM
    Acta Endocrinol (Copenh); 1974 Sep; 77(1):19-25. PubMed ID: 4408390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term administration of medroxyprogesterone acetate (MPA) to acromegalic patients.
    Josefsberg Z; Laron Z; Mathias S; Keret R
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):195-202. PubMed ID: 4837878
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of medroxyprogesterone acetate therapy on carbohydrate metabolism in acromegaly.
    Blum I; Karp M; Laron Z
    Isr J Med Sci; 1972 Jun; 8(6):881-2. PubMed ID: 5051830
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorpromazine treatment and growth hormone secretory responses in acromegaly.
    Dimond RC; Bramer SR; Atkinson RL; Howard WJ; Earll JM
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1189-95. PubMed ID: 4706207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of medroxyprogesterone on plasma somatotropin (GH) levels in 14 patients with acromegaly].
    Tourniaire J; Pousset G
    Ann Endocrinol (Paris); 1973; 34(2):222-4. PubMed ID: 4745280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of medroxyprogesterone acetate in acromegaly.
    Rake JS; Hafiz SA; Lessof MH; Snodgrass GJ
    Clin Endocrinol (Oxf); 1972 Apr; 1(2):181-7. PubMed ID: 4664381
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of CB-154 therapy on the glucose tolerance, IRI and GH response to glucose administration in acromegaly.
    Demura R; Yamaguchi H; Demura H; Shizume K
    Endocrinol Jpn; 1978 Aug; 25(4):355-9. PubMed ID: 710371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins in the medical management of active acromegaly.
    Lawrence AM; Kirsteins L
    J Clin Endocrinol Metab; 1970 May; 30(5):646-52. PubMed ID: 5462817
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly treated with chlorpromazine. A case study.
    Kolodny HD; Sherman L; Singh A; Kim S; Benjamin F
    N Engl J Med; 1971 Apr; 284(15):819-22. PubMed ID: 5549804
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary studies of plasma growth hormone releasing activity during medical therapy of acromegaly.
    Hagen TC; Lawrence AM; Kirsteins L
    Horm Metab Res; 1978 Jul; 10(4):310-3. PubMed ID: 98420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolution of plasma somatotropin levels in acromegaly treated with medroxyprogesterone acetate].
    Strauch G; Bricaire H
    Ann Endocrinol (Paris); 1973; 34(2):228-31. PubMed ID: 4745282
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate (Provera R ) therapy in acromegaly associated with heart disease.
    Wallach HW; Shapiro JR; Mendelson SH
    Med Ann Dist Columbia; 1973 Jan; 42(1):17-22. PubMed ID: 4511103
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of homologous receptor concentrations: a sensitive radioassay for human growth hormone in acromegalic, newborn, and stimulated plasma.
    Rosenfeld RG; Hintz RL
    J Clin Endocrinol Metab; 1980 Jan; 50(1):62-9. PubMed ID: 6243134
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.